Add BrightSurf on Google Email

Inflammation and autoimmune-like dysfunction may play a role in heart failure

A recent study from Penn State College of Medicine researchers found that helper T cells, typically involved in fighting infections, become overly activated in failing human hearts, causing damage. The activation of these T cells highlights the impact of inflammation and immune dysfunction in heart failure.

SourcePenn State·JournalJournal of Molecular and Cellular Cardiology·TypeObservational study·DateJan 27, 2026

How do nature and nurture shape our immune cells?

Researchers at Salk Institute debut an epigenetic catalog that shows genetic inheritance and life experiences have distinct effects on various types of immune cells, shedding light on individual differences in immune responses and potential new personalized therapeutics.

SourceSalk Institute·JournalNature Genetics·DateJan 27, 2026

Discrimination linked to diminished immune system function

Researchers found that people experiencing everyday discrimination have elevated levels of "exhausted" white blood cells, indicating chronic stress may hamper the immune system. This study suggests social experiences like discrimination shape immune health at the cellular level and contribute to biological aging.

SourceNew York University·JournalBrain Behavior & Immunity - Health·DateJan 26, 2026

Itaconate modifications: mechanisms and applications

Researchers summarize itaconate biology highlighting its chemical reactivity and therapeutic potential in treating infectious diseases, sepsis, autoimmunity, neurodegenerative disorders. Itaconate exerts biological effects through post-translational modifications, altering protein activity and signaling pathways

SourceJournal of Intensive Medicine·JournalJournal of Intensive Medicine·TypeLiterature review·DateJan 15, 2026

Sequestered in immune cells, barium titanate nanoparticles stimulated by ultrasound launch inflammatory response

Boston College researchers used piezoelectric nanoparticles to trigger macrophages, a key part of the body's immune response. The study suggests that this method could be used to activate immune cells specifically at an infection or tumor site, avoiding side effects associated with systemic administration of drugs.

SourceBoston College·JournalScientific Reports·TypeExperimental study·DateJan 14, 2026

New study shows how the spleen helps the immune system accept a transplant

Researchers identified the spleen as a key control center for transplant tolerance, triggering donor-specific regulatory T cells to calm the immune response. This targeted approach induces controlled, donor-specific state in T cells, preserving body's ability to fight infections while supporting long-term graft acceptance.

SourceUniversity of Minnesota Medical School·JournalScience Advances·TypeExperimental study·DateJan 7, 2026

Healing the heart after a heart attack

A new patch developed by Texas A&M University researcher Dr. Ke Huang may offer a way to help the heart heal after a heart attack by delivering interleukin-4 directly to damaged heart tissue. The patch uses a microneedle system to promote repair and improve heart function without affecting the rest of the body.

SourceTexas A&M University·JournalCell Biomaterials·DateNov 19, 2025

Chinese Medical Journal Study reveals circulating tumor cells' immune evasion strategies

A recent review in the Chinese Medical Journal uncovers how circulating tumor cells evade immune elimination, highlighting their interactions with immune cells and blood components. The study suggests new therapeutic targets, including anti-platelet therapy and immune checkpoint inhibitors, to combat cancer metastasis.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateNov 6, 2025

Research redefines pneumonia and sepsis care — and exposes urgent gaps in Ireland’s critical care capacity

Two landmark international studies published in The Lancet and Nature Medicine expose the need for faster recognition, better diagnostics, and personalized treatment pathways to combat pneumonia and sepsis. Irish ICUs face a shortage of beds, with implications for delayed care and increased mortality.

SourceTrinity College Dublin·JournalNature Medicine·TypeObservational study·DateNov 3, 2025

Moderate-dose corticosteroid treatment improves patient recovery rates from sepsis

A study published in the Journal of Intensive Medicine found that moderate-dose corticosteroids improve sepsis patient recovery rates by stabilizing immune cells and reducing inflammation. The treatment also shows protective effects on the heart and vascular system, preventing cardiovascular failure and organ damage.

SourceJournal of Intensive Medicine·JournalJournal of Intensive Medicine·TypeSystematic review·DateOct 16, 2025

Checkpoint inhibitor promotes tissue repair

Researchers at UZH have identified a new function of checkpoint inhibitors in promoting tissue healing, which could help treat fibrosis and chronic wounds. The study found that TIGIT upregulates a growth factor critical for repairing tissue after viral infections.

SourceUniversity of Zurich·JournalNature Immunology·TypeExperimental study·DateOct 15, 2025

Mini-organs reveal how the cervix defends itself

Researchers at Aarhus University used mini-organs to show that cervical epithelial cells actively detect and combat infections, with uninfected cells becoming immune-active. This discovery opens opportunities for mucosal vaccines and targeted treatments against STIs and infertility.

SourceAarhus University·JournalScience Advances·DateOct 3, 2025

CDI Lab, HMH specialists identify vital pathway initiating cellular immunity in Science Immunology journal

Researchers at CDI Lab have identified two protein transcription factors, Tcf1 and Lef1, as critical modulators of T cell fate in the thymus. This discovery could lead to novel approaches in treating immune deficiencies, autoimmune diseases, and optimizing immunotherapies in cancer treatment.

SourceHackensack Meridian Health·JournalScience Immunology·TypeExperimental study·DateSep 17, 2025

Preventing corruption in the lymph nodes

Research by Angela Riedel and team identified fibroblastic reticulum cells as main players in reprogramming lymph nodes, corrupting monocytes and blocking T cell activity. Targeted TLR4 blockade combined with PD1 immunotherapy can restore T-cell activity and reduce distant metastasis.

SourceUniversity of Würzburg·JournalImmunity·TypeExperimental study·DateSep 16, 2025